Tetrous Inc.
-
Biologics
Tetrous®Inc. Announces Issue of an Additional U.S. Patent Related to EnFix® Demineralized Bone Fiber Implants for Sports Medicine Surgical Procedures
LOS ANGELES, Oct. 15, 2024 /PRNewswire/ — Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, announced today that a fourth…
Read More » -
Sports Medicine
Tetrous Announces First Surgical Procedures Using EnFix TAC™ Demineralized Bone Fiber Implants to Enhance Enthesis Healing in Rotator Cuff Repair
LOS ANGELES, May 8, 2024 /PRNewswire/ — TETROUS, INC., a leading regenerative medicine company today announced that it has completed the first…
Read More » -
Biologics
Tetrous, Inc. Announces Issue of an Additional U.S. Patent Related to EnFix™ Demineralized Bone Fiber Implants for Sports Medicine Surgical Procedures
LOS ANGELES, Oct. 5, 2023 /PRNewswire/ — Tetrous, Inc., a regenerative medicine company, today announced that another patent (U.S. Patent Number 11,759,548) specifically…
Read More » -
Sports Medicine
First Surgical Procedures In The World Using Tetrous EnFix RC™ Fiber Implant To Enhance Rotator Cuff Repair Performed At Rush Oak Brook Surgery Center
The first four surgical cases with the EnFix RC™ offering surgeons a solution for inadequate healing at the tendon-bone interface.…
Read More »